Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Ritzel

Pharmacokinetic, Insulinotropic, and Glucagonostatic Properties of GLP-1 [7?36 Amide] After Subcutaneous Injection in Healthy Volunteers. Dose-Response-Relationships

Diabetologia

English

Pharmacokinetic, Insulinotropic, and Glucagonostatic Properties of GLP-1 [7?36 Amide] After Subcutaneous Injection in Healthy Volunteers. Dose-Response-Relationships

English

Related publications

Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM

English

Radioimmunoassay for Glucagon-Like Peptide-1 in Human Plasma Using N-Terminal and C-Terminal Directed Antibodies: A Physiologic Insulinotropic Role Oe GLP-1( 7-36 Amide)

English

Central Infusions of Leptin and GLP-1-(7-36) Amide Differentially Stimulate C-Fli in the Rat Brain

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Physiology

1996

English

GLP-1(7—36)amide: Characterization of Its Binding to Specific Receptors in Normal and Tuivioral Rat Islet Cells

English

Pharmacokinetic Interactions of Efavirenz and Voriconazole in Healthy Volunteers

British Journal of Clinical Pharmacology

Pharmacology

2008

English

Testosterone Dose-Response Relationships in Healthy Young Men

American Journal of Physiology - Endocrinology and Metabolism

English

Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2005

English

GLP-1-derived Nonapeptide GLP-1(28-36)amide Represses Hepatic Gluconeogenic Gene Expression and Improves Pyruvate Tolerance in High-Fat Diet-Fed Mice

American Journal of Physiology - Endocrinology and Metabolism

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Ritzel

Pharmacokinetic, Insulinotropic, and Glucagonostatic Properties of GLP-1 [7?36 Amide] After Subcutaneous Injection in Healthy Volunteers. Dose-Response-Relationships

Pharmacokinetic, Insulinotropic, and Glucagonostatic Properties of GLP-1 [7?36 Amide] After Subcutaneous Injection in Healthy Volunteers. Dose-Response-Relationships

Related publications

Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM

Radioimmunoassay for Glucagon-Like Peptide-1 in Human Plasma Using N-Terminal and C-Terminal Directed Antibodies: A Physiologic Insulinotropic Role Oe GLP-1( 7-36 Amide)

Central Infusions of Leptin and GLP-1-(7-36) Amide Differentially Stimulate C-Fli in the Rat Brain

GLP-1(7—36)amide: Characterization of Its Binding to Specific Receptors in Normal and Tuivioral Rat Islet Cells

Pharmacokinetic Interactions of Efavirenz and Voriconazole in Healthy Volunteers

Testosterone Dose-Response Relationships in Healthy Young Men

Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers

GLP-1-derived Nonapeptide GLP-1(28-36)amide Represses Hepatic Gluconeogenic Gene Expression and Improves Pyruvate Tolerance in High-Fat Diet-Fed Mice